Moderna Inc.
34.71
0.25 (0.73%)
At close: Jan 15, 2025, 9:49 AM

Moderna Inc. Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019
Collaboration Arrangement Revenue 7.00M 6.00M 3.00M 0 19.00M 13.00M 2.00M 290.00M 100.00M 35.00M 15.00M 10.00M 23.00M 18.00M 10.00M 78.04M 145.69M 37.91M 3.19M 10.05M 9.61M 9.84M 13.30M
Collaboration Arrangement Revenue Growth +16.67% +100.00% n/a -100.00% +46.15% +550.00% -99.31% +190.00% +185.71% +133.33% +50.00% -56.52% +27.78% +80.00% -87.19% -46.44% +284.33% +1089.49% -68.28% +4.49% -2.32% -26.01% n/a
Grant Revenue 8.00M 20.00M 0 0 44.00M 28.00M 24.00M 0 144.00M 183.00M 126.00M 262.00M 140.00M 139.00M 194.00M 341.37M 12.22M 28.44M 3.93M 3.50M 3.71M 3.05M 1.91M
Grant Revenue Growth -60.00% n/a n/a -100.00% +57.14% +16.67% n/a -100.00% -21.31% +45.24% -51.91% +87.14% +0.72% -28.35% -43.17% +2694.45% -57.05% +623.35% +12.28% -5.56% +21.45% +59.84% n/a
Product Sales Revenue 2.96B 645.00M 522.00M 2.96B 2.42B 1.00B 1.83B 4.08B 3.90B 4.53B 5.92B 0 9.62B 6.14B 4.47B n/a n/a n/a n/a n/a n/a n/a n/a
Product Sales Revenue Growth +359.53% +23.56% -82.34% +22.11% +142.00% -45.30% -55.19% +4.59% -13.93% -23.53% n/a -100.00% +56.47% +37.56% n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Europe Revenue 1.35B 6.82B 6.85B 38.87M
Europe Revenue Growth -80.12% -0.45% +17514.37% n/a
United States Revenue 1.90B 7.30B 5.45B 764.53M
United States Revenue Growth -74.03% +33.96% +612.60% n/a
Rest Of The World Revenue 3.60B 5.15B 6.18B n/a
Rest Of The World Revenue Growth -30.14% -16.63% n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017
Selling, General, and Administrative Revenue 281.00M 268.00M 274.00M 470.00M 442.00M 332.00M 305.00M 375.00M 278.00M 211.00M 268.00M 201.00M 168.00M 121.00M 77.00M 78.99M 48.54M 36.62M 24.11M 25.86M 28.19M 28.52M 27.28M 38.02M 18.52M 21.39M 16.32M 15.90M 16.73M 16.04M 16.04M
Selling, General, and Administrative Revenue Growth +4.85% -2.19% -41.70% +6.33% +33.13% +8.85% -18.67% +34.89% +31.75% -21.27% +33.33% +19.64% +38.84% +57.14% -2.52% +62.73% +32.55% +51.87% -6.74% -8.27% -1.17% +4.54% -28.25% +105.25% -13.38% +31.07% +2.59% -4.93% +4.28% n/a n/a
Research and Development Revenue 1.14B 1.18B 1.03B 1.41B 1.16B 1.15B 1.13B 1.21B 820.00M 710.00M 554.00M 648.00M 521.00M 421.00M 401.00M 758.86M 344.49M 151.86M 115.14M 118.75M 119.72M 128.50M 130.57M 150.43M 109.05M 104.48M 90.12M 117.83M 93.61M 99.51M 99.51M
Research and Development Revenue Growth -3.64% +14.90% -26.96% +21.21% +1.05% +1.50% -6.61% +47.68% +15.49% +28.16% -14.51% +24.38% +23.75% +4.99% -47.16% +120.29% +126.85% +31.89% -3.05% -0.80% -6.83% -1.59% -13.20% +37.94% +4.38% +15.93% -23.51% +25.87% -5.93% n/a n/a